Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the ...

Satellos Bioscience Inc. ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today ...

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

Wells Fargo analyst Eva Fortea Verdejo initiated coverage of Merus (MRUS) with an Overweight rating and $91 price target The firm thinks ...

Figure 5: Telomere dysfunction peaks at the adenoma-carcinoma transition in human colorectal carcinogenesis. Whole-mount staining/analysis of micro- and macroadenomas. The complete small and large ...

Today, on World Cancer Day, we come together to raise awareness, promote early detection and encourage prevention.

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Dana Walker, vice president, Opdivo global programme lead, BMS, said: “HCC is the predominant type of liver cancer globally, including in the EU, and when diagnosed at the advanced or unresectable ...